2017 American Transplant Congress
Risk Factors and 2 Year Outcomes of Low Estimated Glomerular Filtration Rate in the Immediate Post-Operative Period for Living Kidney Donors.
1Henry Ford Hospital, Detroit; 2Wayne State University, Detroit
Background: While long-term risk of end-stage renal disease in living kidney donors is considered less than 0.25% at 15 years, an association between the immediate…2017 American Transplant Congress
Serum Phosphorus and Cardiovascular Disease Outcomes, Graft Failure, or Total Mortality in Chronic Kidney Transplant Recipients.
Mild hyperphosphatemia may be present in chronic kidney transplant recipients [KTRs]. Limited data are available from large, multicenter KTR cohorts assessing the potential relationships between…2017 American Transplant Congress
Post-Liver Transplant (LT) Early Allograft Dysfunction (EAD) Modulates the Effect of Pre-LT Kidney Function on Post-LT Survival.
Transplant, Mayo Clinic, Jackosonville, FL
The impact of EAD on post-LT renal recovery remains unknown. Aim: To assess the impact of post-LT EAD on renal recovery and post-LT survival. Methods:…2017 American Transplant Congress
Long-Term Outcomes of Renal Function in Pediatric Living Related Intestinal Transplantation.
1Surgery, UIC, Chicago, IL; 2Pediatrics, UIC, Chicago, IL; 3Surgery, Baylor University, Texas
Background: Renal function after organ transplantation is affected by several factors. The use of calcineurin inhibitors has a direct impact on the kidney. Material and…2017 American Transplant Congress
Benefit of Anti-Hepatitis B Immunoglobulin(HBIG) Monotherapy Compared to HBIG Combined with Entecavir in Long Term Renal Function.
Background: To reduce the HBV reinfection after liver transplantation, anti-hepatitis B immunoglobulin (HBIG) alone or combination with antiviral nucleotide analogues are usually used regimen. However,…2017 American Transplant Congress
Renal Function After Liver Transplantation Alone in Patients Meeting the Proposed UNOS Simultaneous Liver-Kidney (SLK) Criteria.
Background & Aim: The United Network for Organ Sharing (UNOS) has proposed criteria for simultaneous liver and kidney transplantation (SLK) incorporating strict definitions for eligibility…2017 American Transplant Congress
Bortezomib for Late Antibody-Mediated Rejection After Renal Transplantation: A Single Center Experience of 22 Cases.
Despite of tradifional treatments for AMR, such as plasapheresis, ingravenous immunoglobulin, and rituximab, current treatment for antibody-mediated rejection(AMR) after renal transplantation is insufficient. Recently, Bortezomib…2017 American Transplant Congress
Long-Term Preservation of Renal Function in Liver Transplant Recipients with Rabbit Anti-Thymocyte Globulin Induction and Delayed Initiation of Calcineurin Inhibitors.
Transplant Institute, Henry Ford Health System, Detroit, MI
Methods: A single-center retrospective analysis of medical records of 989 liver transplant recipients from 2001-2010 were reviewed and evaluated for patients who received thymo induction…2017 American Transplant Congress
Effect of Hypothermic Pulsatile Machine Perfusion on Kidney Delayed Graft Function in Simultaneous Liver-Kidney Transplantation: A Single Center Study.
OBJECTIVE: Assessment of risk factors correlated with the development of kidney delayed graft function (kDGF) among recipients of simultaneous liver-kidney transplant (SLKT).BACKGROUND: Renal dysfunction occurs…2017 American Transplant Congress
Effect of Blood Pressure Just Before Release of the Vascular Clamps on the Renal Function of Kidney Transplantation Recipients: A Retrospective Study.
OBJECTIVE: To assess the effect of blood pressure just before release of the vascular clamps on the renal function of kidney transplantation (KTx) recipients.METHODS: We…
- « Previous Page
- 1
- …
- 18
- 19
- 20
- 21
- 22
- …
- 27
- Next Page »